Pierre Fabre at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Pierre Fabre takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8025. Its program centres on metastatic colorectal cancer driven by the BRAF V600E mutation. The discussion focuses on putting precision medicine into routine practice for these patients.

OrganizationESMO 2026 Attendance
pierre-fabre.com
Large pharmaExhibitor
French pharmaceutical group whose oncology portfolio includes targeted therapies for BRAF-mutant melanoma and colorectal cancer.
Booth
Exhibiting at Booth 8025
Satellite
Sun Oct 25
13:00–14:30
Pierre Fabre Laboratories - BRAFV600E-mutant mCRC: Precision medicine in practice
Sponsored session · with Vall d'Hebron University Hospital
Gastrointestinal cancersBiomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Pierre Fabre

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction